Neurokinin A vs Neurokinin B — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Neurokinin A (NKA) is a 10-amino acid tachykinin neuropeptide encoded by the tachykinin precursor 1 (TAC1) gene, the same gene that produces substance P. NKA and substance P share the C-terminal sequence Phe-X-Gly-Leu-Met-NH2 characteristic of all tachykinins....
Calculate Neurokinin A dose →Neurokinin B (NKB) is a 10-amino acid tachykinin encoded by the TAC3 gene, preferentially activating NK3 receptors (NK3R). NKB is co-expressed with kisspeptin and dynorphin in hypothalamic arcuate nucleus neurons, collectively called KNDy neurons, forming the pulse generator for ...
Calculate Neurokinin B dose →| Parameter | Neurokinin A | Neurokinin B |
|---|---|---|
| Category | Tachykinin Neuropeptide | Tachykinin Neuropeptide |
| Research | Research | Clinical |
| Half-Life | Short (minutes) | Short (minutes) |
| Typical Dose | 0.1-10 nmol/kg (animal) | 0.1-1 nmol/kg (research) |
| Frequency | Variable | Variable |
| Route | Intravenous, Subcutaneous, Inhalation (research) | Intravenous (research) |
| FDA Status | Not approved | Not approved (NK3R antagonists FDA-approved) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.